September/October 2022 - Volume 42 - Issue 5 - Contributor Index

Alphabetical Search
I
U
Author:
Adams, Julie MD

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Author:
Barer, Yael MSc

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Author:
Gao, Zhi-Han MM

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Author:
Han, Tommy HBSc

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Author:
Kohegyi, Eva MD

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Author:
Logan, John MSc
Author:
Lutz, Justina

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Author:
Maglio, Gino MD

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials

Adler, Lenard A.; Adams, Julie; Madera-McDonough, Jessica; More

Journal of Clinical Psychopharmacology. 42(5):429-439, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Author:
Pani, Luca MD

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis

Perivolaris, Argyrios; Ainsworth, Nicholas J.; Alexopoulos, George S.; More

Journal of Clinical Psychopharmacology. 42(5):489-494, September/October 2022.

REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases

Guidetti, Clotilde; Serra, Giulia; Pani, Luca; More

Journal of Clinical Psychopharmacology. 42(5):503-506, September/October 2022.